Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema [Phase 3]
Phase 3 trial evaluating Faricimab for Diabetic Macular Edema has completed and results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Intravitreal Ranibizumab Versus Its Combination With Dexamethasone in The Treatment of Diabetic Macular Edema [Phase 3]
Phase 3 trial comparing intravitreal ranibizumab alone to its combination with dexamethasone for diabetic macular edema has completed.
-
FDA approval · 2022-01-28FDA Approved: VABYSMO — Original Application (Genentech, Inc.)
FDA approves VABYSMO (faricimab) for the treatment of neovascular age-related macular degeneration and diabetic macular edema under the orig…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Phase 4 IOP Signals Associated With ILUVIEN® [Phase 4]
Phase 4 trial update for ILUVIEN® signals associated with intraocular pressure (IOP) in diabetic macular edema patients.
-
CLINICAL_TRIALS research · 2021-12-03Clinical Trial Update: Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema [Phase 4]
Phase 4 trial update examining bevacizumab and peripheral retinal changes on wide-field angiography in diabetic retinopathy and diabetic mac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Anti-VEGF Treatment for Prevention of PDR/DME [Phase 3]
Phase 3 trial update for an anti-VEGF treatment aimed at preventing proliferative diabetic retinopathy and diabetic macular edema; study com…
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular Edema [Phase 2, Phase 3]
A phase 2/3 trial is evaluating combined intravitreal bevacizumab with topical timolol-dorzolamide eye drops for diabetic macular edema.
-
FDA approval · 2021-09-17FDA Approved: BYOOVIZ — Original Application (BIOGEN INC.)
BYOOVIZ, Biogen's ranibizumab-nuna biosimilar, has been approved by the FDA through its Original Application, with indications matching thos…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion [Phase 2]
Phase 2 clinical trial update for a depot formulation of sunitinib malate (GB-102) in diabetic macular edema and retinal vein occlusion has …
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates [Phase 1, Phase 2]
Phase 1/2 trial evaluating intravitreal ranibizumab for diabetic macular edema with center-involved edema and lipid exudates; study complete…
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema [Phase 2]
A Phase 2 trial comparing suprachoroidal CLS-TA with intravitreal aflibercept versus aflibercept alone in diabetic macular edema has complet…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept [Phase 4]
Phase 4 trial update exploring cytokine and visual outcomes in eyes treated with aflibercept for age-related macular degeneration and diabet…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab [Phase 4]
Phase 4 trial exploring how cytokine changes relate to visual outcomes in eyes treated with ranibizumab for macular diseases.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema [Phase 1, Phase 2]
Clinical trial update on suprachoroidal CLS-TA alone or with aflibercept in diabetic macular edema (Phase 1/2) completed with results posted…
-
CLINICAL_TRIALS withdrawal · 2021-03-04Clinical Trial Update: Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema [Phase 3]
Phase 3 trial comparing brolucizumab to aflibercept for diabetic macular edema was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Short-term Additive Effect of Topical Ketorolac on the Management of Diabetic Macular Edema With Intravitreal Bevacizumab [Phase 2, Phase 3]
Phase 2/3 trial evaluating the short-term additive effect of topical ketorolac on management of diabetic macular edema with intravitreal bev…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema [Phase 3]
Phase 3 trial comparing Triamcinolone Acetonide with Laser or Bevacizumab with Laser versus Laser Alone for diffuse non-tractional diabetic …
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema [NA]
Exploratory study of KPI-121 on intra- or subretinal fluid due to retinal vein occlusion and diabetic macular edema has completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME) [Phase 2]
Phase 2 trial of intravitreal KVD001 for center-involving diabetic macular edema has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema [Phase 3]
A Phase 3 trial comparing dexamethasone versus laser photocoagulation for diabetic macular edema has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema [Phase 1, Phase 2]
A safety and efficacy trial exploring a treat-and-extend approach with ranibizumab, with or without laser photocoagulation, for diabetic mac…
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO [Phase 4]
Phase 4 trial comparing intravitreal dexamethasone to bevacizumab in Aboriginal people with diabetic macular edema and diabetic retinopathy …
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase [Phase 3]
A Phase 3 clinical trial update on Lucentis (ranibizumab) assessing efficacy and safety in diabetic macular edema and related macular condit…
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium [Phase 4]
A Phase 4 extension study assessing the effect of Macugen on the corneal endothelium has completed, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema [Phase 2]
Phase 2 trial assessing faricimab in center-involving diabetic macular edema has completed with results posted.